Induced Pluripotent Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Induced Pluripotent Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Induced Pluripotent Stem Cell Market by Workflow
3.3.1: Reprogramming
3.3.2: Cell Culture
3.3.3: Cell Characterization / Analysis
3.3.4: Engineering
3.3.5: Others
3.4: Global Induced Pluripotent Stem Cell Market by Application
3.4.1: Drug Development & Discovery
3.4.2: Regenerative Medicine
3.4.3: Toxicology Studies
3.4.4: Others
3.5: Global Induced Pluripotent Stem Cell Market by End Use
3.5.1: Research & Academic Institutes
3.5.2: Biotechnology & Pharmaceutical Companies
3.5.3: Hospitals & Clinics
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Induced Pluripotent Stem Cell Market by Region
4.2: North American Induced Pluripotent Stem Cell Market
4.2.1: North American Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.2.2: North American Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
4.3: European Induced Pluripotent Stem Cell Market
4.3.1: European Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.3.2: European Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
4.4: APAC Induced Pluripotent Stem Cell Market
4.4.1: APAC Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.4.2: APAC Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
4.5: ROW Induced Pluripotent Stem Cell Market
4.5.1: ROW Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.5.2: ROW Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Workflow
6.1.2: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Application
6.1.3: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by End Use
6.1.4: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Region
6.2: Emerging Trends in the Global Induced Pluripotent Stem Cell Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Induced Pluripotent Stem Cell Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Induced Pluripotent Stem Cell Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Lonza
7.2: Axol Bioscience
7.3: Evotec
7.4: Hitachi
7.5: REPROCELL
7.6: Merck
7.7: REPROCELLS
7.8: Fate Therapeutics
7.9: Thermo Fisher Scientific
7.10: StemCellsFactory III
2. GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Induced Pluripotent Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Induced Pluripotent Stem Cell Market by Workflow
3.3.1: Reprogramming
3.3.2: Cell Culture
3.3.3: Cell Characterization / Analysis
3.3.4: Engineering
3.3.5: Others
3.4: Global Induced Pluripotent Stem Cell Market by Application
3.4.1: Drug Development & Discovery
3.4.2: Regenerative Medicine
3.4.3: Toxicology Studies
3.4.4: Others
3.5: Global Induced Pluripotent Stem Cell Market by End Use
3.5.1: Research & Academic Institutes
3.5.2: Biotechnology & Pharmaceutical Companies
3.5.3: Hospitals & Clinics
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Induced Pluripotent Stem Cell Market by Region
4.2: North American Induced Pluripotent Stem Cell Market
4.2.1: North American Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.2.2: North American Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
4.3: European Induced Pluripotent Stem Cell Market
4.3.1: European Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.3.2: European Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
4.4: APAC Induced Pluripotent Stem Cell Market
4.4.1: APAC Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.4.2: APAC Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
4.5: ROW Induced Pluripotent Stem Cell Market
4.5.1: ROW Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
4.5.2: ROW Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Workflow
6.1.2: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Application
6.1.3: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by End Use
6.1.4: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Region
6.2: Emerging Trends in the Global Induced Pluripotent Stem Cell Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Induced Pluripotent Stem Cell Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Induced Pluripotent Stem Cell Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Lonza
7.2: Axol Bioscience
7.3: Evotec
7.4: Hitachi
7.5: REPROCELL
7.6: Merck
7.7: REPROCELLS
7.8: Fate Therapeutics
7.9: Thermo Fisher Scientific
7.10: StemCellsFactory III
